UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017225
Receipt number R000019979
Scientific Title Study on Pharmacokinetics and Pharmacodynamics of high dose Meropenem.
Date of disclosure of the study information 2015/04/21
Last modified on 2017/10/25 20:49:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on Pharmacokinetics and Pharmacodynamics of high dose Meropenem.

Acronym

Study on Pharmacokinetics and Pharmacodynamics of high dose Meropenem.

Scientific Title

Study on Pharmacokinetics and Pharmacodynamics of high dose Meropenem.

Scientific Title:Acronym

Study on Pharmacokinetics and Pharmacodynamics of high dose Meropenem.

Region

Japan


Condition

Condition

infectious disease

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

An evaluation of the efficacy and safety

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

An evaluation of the efficacy and safety

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Measurements of blood concentration of Meropenem and an evaluation of the efficacy and safety

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

In patients treated with Meropenem

Key exclusion criteria

Nothing

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Naoki Hasegawa

Organization

Keio University School of Medicine

Division name

Center of Infectious Diseases and Infection Control

Zip code


Address

35 Shinanomachi Shinjyukuku Tokyo

TEL

03-3353-1211

Email

n-hasegawa@z8.keio.jp


Public contact

Name of contact person

1st name
Middle name
Last name Osamu Iketani

Organization

Keio University Hospital

Division name

Center of Infectious Diseases and Infection Control

Zip code


Address

35 Shinanomachi Shinjyukuku Tokyo

TEL

03-3353-1211

Homepage URL


Email

osamu.iketani@adst.keio.ac.jp


Sponsor or person

Institute

Keio University

Institute

Department

Personal name



Funding Source

Organization

Keio University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 04 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2014 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2015 Year 04 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 04 Month 21 Day

Last modified on

2017 Year 10 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019979


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name